Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001662774-24-000011
Filing Date
2024-11-13
Accepted
2024-11-13 17:09:23
Documents
95
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qncx-20240930.htm   iXBRL 10-Q 1816823
2 EX-31.1 qncx-20240930xexx311.htm EX-31.1 10022
3 EX-31.2 qncx-20240930xexx312.htm EX-31.2 10257
4 EX-32.1 qncx-20240930xexx321.htm EX-32.1 6834
5 EX-32.2 qncx-20240930xexx322.htm EX-32.2 6872
11 qncx-20240930_g1.jpg GRAPHIC 213125
12 qncx-20240930_g2.jpg GRAPHIC 118897
13 qncx-20240930_g3.jpg GRAPHIC 190353
14 qncx-20240930_g4.jpg GRAPHIC 167618
15 qncx-20240930_g5.jpg GRAPHIC 290569
  Complete submission text file 0001662774-24-000011.txt   11059038

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qncx-20240930.xsd EX-101.SCH 61615
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qncx-20240930_cal.xml EX-101.CAL 92897
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qncx-20240930_def.xml EX-101.DEF 364180
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qncx-20240930_lab.xml EX-101.LAB 655281
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qncx-20240930_pre.xml EX-101.PRE 549280
98 EXTRACTED XBRL INSTANCE DOCUMENT qncx-20240930_htm.xml XML 1154433
Mailing Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Filer) CIK: 0001662774 (see all company filings)

EIN.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38890 | Film No.: 241455572
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)